electrolyte, where the only species contributing to oxidation are:
Removal of the selective hydroxyl radical probe, pCBA, in all the electrolytes except 131 ammonia indicated that [HO • ] ୗୗ had a negligible contribution to contaminant transformation.
132
Therefore, dissolved hydroxyl radical can be ignored here on out and the contributing species 133 in borate electrolysis are:
Tertiary butanol or allyl alcohol can be used as selective probes to discern between the HOCl. The predicted transformation of contaminants in the presence of Cl -was calculated as
where k HOCl is the bimolecular rate constant of the HOCl with trace organic contaminants 140 (Table 1) . HOCl production is pseudo-zeroth order with respect to Cl -and can be expressed as
141
(SI Section 2.6; Figure S6 ): given in Table S4 . The value of t was selected as the time needed for roughly 95% of the 144 compound removal (using the pseudo-first order observed removal rates; = 20 µM) and is continually re-oxidized after HOBr reacts with contaminants. As a result, we 157 rewrite the expression for the observed degradation as:
The value of t was selected as the time needed for roughly 95% of the compound removal
159
(using the pseudo-first order observed removal rates; removal rates was estimated using scaling factors determined in Figure 4 (i.e., k Br,HCO 3 / k Br) : The production of HOCl in the presence of NOM can be described by:
where k' HOCl is the zero-order production rate of HOCl in the presence of 10 mM NaCl, and k Table S4 . Bimolecular rate constants for the reaction between HOCl, HOBr, and radical 212 species for the trace organic contaminants and probes used in this study. for the electrolytes used in Figure 2 . Carbamazepine 5.7 × 10 -3 ± 11% 4.7 × 10 -3 ± 13% 1.5 × 10 -3 ± 21% 1.1 × 10 -2 ± 34% Atenolol 1.3 × 10 -3 ± 6% 2.4 × 10 -3 ± 4% 6.5 × 10 -4 ± 12% 3.6 × 10 -3 ± 19% Metoprolol 2.0 × 10 -3 ± 16% 2.5 × 10 -3 ± 3% 9.0 × 10 -4 ± 13% 5.4 × 10 -3 ± 9% Propranolol 1.2 × 10 -2 ± 51% 1.7 × 10 -2 ± 4% 7.0 × 10 -3 ± 33% 1.7 × 10 -2 ± 13% Trimethoprim 1.3 × 10 -2 ± 6% 2.2 × 10 -2 ± 3% 1.1 × 10 -2 ± 57% 2.2 × 10 -2 ± 7% Sulfamethoxazole 2.7 × 10 -2 ± 29% 4.1 × 10 -2 ± 15% 4.2 × 10 -2 ± 10% 4.9 × 10 -2 ± 0.2% Acetaminophen 2.9 × 10 -2 ± 22% 3.4 × 10 -2 ± 6% 2.6 × 10 -2 ± 9% 2.6 × 10 -2 ± 1% Acyclovir 1.2 × 10 -2 ± 6% 3.1 × 10 -2 ± 9% 7.5 × 10 -3 ± 14% 4.6 × 10 -2 ± 4% Abacavir 1.6 × 10 -2 ± 13% 3.1 × 10 -2 ± 5% 1.6 × 10 -2 ± 16% 4.5 × 10 -2 ± 27% 242 243
BDD
244 245 Table S8 . Pseudo-first order transformation rates for trace organic contaminants at pH 8 on
246
BDD for the electrolytes used in Figure S20 .
247
Cl + Allyl Alcohol Cl + t-BuoH Cl Borate Atrazine 1.9 × 10 -5 ± 27% 1.1 × 10 -5 ± 82% 2.1 × 10 -4 ± 45% 2.0 × 10 -5 ± 19% Isoproturon 2.9 × 10 -5 ± 123% 7.7 × 10 -5 ± 20% 9.1 × 10 -4 ± 34% 8.3 × 10 -5 ± 37% Carbamazepine 2.5 × 10 -5 ± 86% 7.1 × 10 -5 ± 31% 5.7 × 10 -4 ± 5% 2.8 × 10 -4 ± 16% Atenolol 1.4 × 10 -5 ± 15% 3.2 × 10 -5 ± 1% 1.3 × 10 -4 ± 14% 4.2 × 10 -5 ± 3% Metoprolol 6.8 × 10 -5 ± 30% 4.9 × 10 -4 ± 11% 6.1 × 10 -4 ± 4% 4.2 × 10 -4 ± 70% Trimethoprim 3.5 × 10 -5 ± 44% 1.9 × 10 -4 ± 41% 2.5 × 10 -3 ± 6% 2.1 × 10 -4 ± 1% Sulfamethoxazole 3.6 × 10 -5 ± 84% 2.8 × 10 -4 ± 60% 4.8 × 10 -3 ± 6% 2.4 × 10 -4 ± 40% Acetaminophen 9.7 × 10 -5 ± 5% 1.1 × 10 -4 ± 67% 5.1 × 10 -3 ± 22% 3.7 × 10 -4 ± 24% Acyclovir 2.5 × 10 -5 ± 1% 1.0 × 10 -4 ± 49% 1.6 × 10 -3 ± 1% 7.6 × 10 -5 ± 26% Abacavir 1.3 × 10 -5 ± 42% 1.6 × 10 -4 ± 39% 3.6 × 10 -3 ± 21% 7.0 × 10 -4 ± 6% 
